Overcoming the Allogeneic Immune Barrier for Off-the-Shelf iPSC-Derived Therapies

Time: 2:30 pm
day: Day 2 Track 1 PM Clarice

Details:

  • Determining effective methods to avoid therapy removal by the immune system
  • Encapsulating iPSC-derived cells to deter immune recognition
  • Developing a universal iPSC to tackle allogeneic immune rejection

Speakers: